Answers are grounded in this paper and cite their sources.
Perioperative myocardial infarction is a major complication that significantly affects patient prognosis. Surgical invasion and anesthesia significantly change perioperative hemodynamics, and increases the risk of myocardial ischemia. Lidocaine, an anesthetic agent that has been commonly used for local anesthesia during dental procedures, is often used for the treatment of ventricular arrhythmias associated with acute myocardial infarction. It has been reported that lidocaine exerts a pharmacological preconditioning effect similar to that of volatile anesthetics, and that administration of lidocaine before and during myocardial ischemia decreases infarct size after reperfusion and lessens myocardial injury. However, although many studies on myocardial ischemic preconditioning and pharmacological preconditioning mainly with volatile anesthetic agents have been conducted as ex vivo studies using isolated hearts, 6 the number of in vivo studies is limited. It has been suggested that lidocaine exerts its myocardial protective effect only when administered at high doses prior to ischemia, and it is largely unknown whether lidocaine given after the initiation of reperfusion protects myocardium. In the present study, lidocaine was continuously adLidocaine protects against myocardial ischemia-reperfusion injury in anesthetized rabbits
No takes yet. Share an insight, caveat, or question.
Yamabayashi et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: